Olympex Solutions

Read off the catalogue page with nothing in the basket and no account. OS-3 RT shows 99.87% against lot OSL-GLP3RT10-02, GHK-Cu 99.87% against OSL-GHKCU50-01, Tesamorelin 99.80% against OSL-TSM10-02, Thymosin Alpha-1 99.02% against OSL-TA1-01. Every listing carries both. This is the furthest any vendor in our catalogue goes, because it answers which lot and how pure before the purchase rather than after it.

They run from 99.02% on Thymosin Alpha-1 to 99.94% on cagrilintide, with Sermorelin at 99.27%, DSIP at 99.49% and IGF-1 LR3 at 99.51%. A set of numbers that all read 99.9% would be a marketing decision rather than a measurement. A spread that includes a 99.02% and publishes it anyway is the shape real measurement takes.

5% at two or more vials, 10% at three or more, 15% at ten or more, stated as mix any vials and no code needed. The per-vial discounted price is printed under each product, so a 2+ price of $42.74 against $44.99 is visible before checkout rather than appearing at it.

Cagrilintide is described as a 37-residue acylated analogue of human amylin characterised at the amylin and calcitonin receptors. PT-141 as a cyclic heptapeptide melanocortin agonist derived from Melanotan 2 by C-terminal deamidation. AOD-9604 as a modified C-terminal fragment, residues 177 to 191, of human growth hormone with an added N-terminal tyrosine. That's accurate pharmacology rather than benefit copy, and it's rare.

The homepage states that every lot is tested by an independent laboratory before listing, and a Certificates section sits in the main navigation. The purity figures are consistent with that. We haven't audited the issuing laboratory or opened a certificate for every lot, so while the claim is specific and checkable per product, which beats most, it's still the vendor describing its own process.

Cards carry 1,200+ sold this month, 220+ sold this month, and ONLY 3 LEFT badges. None of it is verifiable from outside, all of it is controlled by the seller, and all of it creates urgency. It sits oddly beside the genuinely good disclosure above it, and it is the one part of the page we would ignore.